glp 1 mrna GLP-1R, GIPR and GCGR Cell Lines for Research GLP-1 Receptor Agonists in Neurodegeneration:

Description

The overall effect of treatment was calculated as weighted average of the inverse variance adjusted individual effects

The appetite suppression these drugs create makes it difficult to eat enough protein to preserve muscle mass, and roughly 25% of weight lost on GLP-1 drugs comes from lean tissue on average, with some trials reporting up to 40%

Nonetheless, this is not an unqualified panacea

Statements Data availability statement The original contributions presented in the study are included in the article/ Supplementary Materials , further inquiries can be directed to the corresponding author/s